軽症脳梗塞に対するクリティカルパスの臨床効果

DOI Web Site

書誌事項

タイトル別名
  • Clinical effect of critical pathway for the patient with mild stroke
  • ケイショウ ノウ コウソク ニ タイスル クリティカルパス ノ リンショウ コウカ

この論文をさがす

説明

The patients with cerebral infarction show variable neurological symptoms and variable pattern of recovery. Critical pathway is the method to facilitate recovery by standardizing the course of therapy and care. Validity of critical pathway for the patient with cerebral infarction has not established yet. We developed critical pathway for the patient with acute mild cerebral infarction and analyzed clinical effect of the pathway. This is historically controlled non-randomized study. The control group includes 37 patients admitted between August and November in 2003, before the introduction of the critical pathway. The critical pathway was used for 35 patients admitted between November 2003 and May 2004. Among these 35 patients, only 1 patient failed to complete the pathway, because he developed pneumonia after admission. So critical pathway group included 34 cases that completed the pathway. Our stroke critical pathway includes the order of the infusion of anti-platelet drug (Ozagrel Na, Cataclot ®) and free radical scavenger (Edaravone, Radicut ®) for 2 weeks. The length of stay and infusion was determined by the doctor in charge, depend on the patient condition. There were no significant differences in backgrounds, symptoms, responsible lesions, neurological findings, ADL, complications, accompanying diseases between control and pathway groups. Neurological complications were seen in only control group, not in critical pathway group. There were significant improvements in NIHSS in both groups. This result means the introduction of critical pathway for the management of acute stroke patient does not bring significant clinical improvement. In our literature review, clinical effectiveness of critical pathway for the management of acute stroke patient was not reported in the literature. Critical pathway is most effective for the disease with predictable course. Because control group received effective standard therapy before the introduction of critical pathway, the clinical effect of critical pathway was not significant.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ